Last edition
News about "Blood Disorders"
Damora Therapeutics Launches Global Phase 1/1b Trial of DMR-001 for mutCALR-Driven Blood Cancers
Damora Therapeutics initiates the global CLARITY-101 clinical trial to assess DMR-001, a novel mutation-targeted therapy designed to address the underlying cause of mutCALR-driven blood disorders.
Blood Disorders | 07/08/2026 | By News Bureau
Marengo Asia Hospitals, Gurugram, showcased its 1,400 bone marrow transplants while highlighting emerging therapies such as gene editing and cellular treatments that are reshaping the future of blood disease care.
Blood Disorders | 18/06/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy